Psyence Biomedical Ltd.
PBM
$3.48
-$0.08-2.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.44M | 7.44M | 7.15M | 6.14M | 6.14M |
| Total Receivables | 362.80K | 362.80K | 174.20K | -- | 137.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.26M | 1.26M | 258.10K | -- | 251.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 47.20K | 47.20K | 47.20K | -- | 36.00K |
| Total Current Assets | 9.11M | 9.11M | 7.63M | -- | 6.56M |
|
|
|||||
| Total Current Assets | 9.11M | 9.11M | 7.63M | -- | 6.56M |
| Net Property, Plant & Equipment | 6.10K | 6.10K | 8.70K | -- | 11.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 389.80K | 389.80K | -- | -- | -- |
| Total Assets | 17.57M | 17.57M | 12.81M | -- | 7.32M |
|
|
|||||
| Total Accounts Payable | 229.50K | 229.50K | 235.90K | -- | 261.90K |
| Total Accrued Expenses | 84.70K | 84.70K | 104.90K | -- | 50.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 309.00K | 309.00K | 602.30K | -- | 281.90K |
| Total Other Current Liabilities | 309.00K | 309.00K | 602.30K | -- | 281.90K |
| Total Current Liabilities | 623.20K | 623.20K | 943.10K | -- | 594.40K |
|
|
|||||
| Total Current Liabilities | 623.20K | 623.20K | 943.10K | -- | 594.40K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 623.20K | 623.20K | 943.10K | -- | 594.40K |
|
|
|||||
| Common Stock & APIC | 78.75M | 78.75M | 68.88M | -- | 61.75M |
| Retained Earnings | -63.38M | -63.38M | -58.44M | -- | -56.45M |
| Treasury Stock & Other | 1.58M | 1.58M | 1.42M | -- | 1.42M |
| Total Common Equity | 16.94M | 16.94M | 11.87M | 6.72M | 6.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.94M | 16.94M | 11.87M | 6.72M | 6.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.94M | 16.94M | 11.87M | 6.72M | 6.72M |
|
|
|||||